NYSE$NUS

Nu Skin Enterprises Inc · Q3 2023 earnings

Q3 2023 earnings · · Investor relations

Briefing

Nu Skin's Q3 2023 results were softer than expected due to macro-economic challenges, particularly in Mainland China and the Americas, and a strong U.S. dollar, but stabilization and modest growth was seen in three Nu Skin reporting segments and accelerated growth in Rhyz businesses.

Nu Skin Enterprises reported Q3 2023 revenue of $498.8 million, a decrease compared to $537.8 million in the prior-year quarter. The company experienced a loss per share (EPS) of $(0.74), or $0.56 excluding an inventory write-off, compared to $(0.51) or $0.47 excluding restructuring and impairment charges in the prior year. The company is strategically re-evaluating several aspects of its Nu Skin business, including product portfolio, global processes and organization, and operational footprint and aggressively managing costs to help drive growth and profitability.

  • Revenue was $498.8 million, compared to $537.8 million in the prior-year quarter, impacted by foreign exchange rates by (1)%.
  • Loss per share (EPS) was $(0.74), or $0.56 excluding an inventory write-off, compared to $(0.51) or $0.47 excluding restructuring and impairment charges in the prior year.
  • The company is strategically re-evaluating several aspects of its Nu Skin business, including product portfolio, global processes and organization, and operational footprint.
  • A new mental wellness category will be introduced in 2024.

Headline financials

Total Revenue

$499M

Previous: $538M-7.3%
EPS (adj)

$0.56

Previous: $0.47+19.1%
Customers

978.9K

Previous: 1.2M-21.0%
Paid Affiliates

186.2K

Previous: 243.3K-23.5%
Sales Leaders

47.0K

Previous: 49.8K-5.6%
Capital Expenditures

-$38.1M

Previous: -$25.5M-49.7%
Free Cash Flow

-$75.1M

Previous: -$50.8M-47.6%
Net Income

-$37M

Previous: -$25.4M-45.5%
Operating Income

-$26.4M

Previous: -$20.3M-30.0%
Gross Profit

$292M

Previous: $364M-19.8%
Cash & Equivalents

$233M

Previous: $294M-20.7%
Total Assets

$1.79B

Previous: $1.76B+1.7%
Stock-Based Comp

$3.73M

Previous: $3.17M+17.5%

Revenue & EPS history

Nu Skin · Revenue · Quarterly

$499M

Q3 2023-7.3%vs Q3 2022
Beat estimate in 4 of 15 quarters(27%)
ActualEstimate

Revenue by segment

Nu Skin · $449M total across 2 segments · Q3 2023

  • Total Nu Skin
    $438M
  • Rhyz Other
    $10.8M+1909.9%

Forward guidance

For Q4 2023, Nu Skin anticipates revenue between $440 to $480 million, with an approximate 3 percent negative foreign currency impact. Reported earnings per share are projected to be $(0.14) to $0.01, or $0.15 to $0.30 when excluding a fourth quarter restructuring charge.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q3 2023

Historical avgQ3 2023

-0.9%

Avg return

Earnings day

-0.7%

Avg return

5 days after

-2.1%

Avg return

30 days after

41%

28 / 68 earnings

Positive

+28.3%

Q1 2020

Best reaction

-20.5%

Q4 2023

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+1.3%-10.3%-23.4%
Q4 2025-18.1%-16.7%-29.8%
Q3 2025-15.9%-11.4%-7.8%
Q1 2025+11.2%+18.8%+28.7%
Q4 2024+17.8%+22.0%+26.5%
Q3 2024+1.1%+11.6%+15.7%
Q2 2024-4.0%-9.9%-23.7%
Q1 2024+4.3%+10.3%+8.1%
Q4 2023-20.5%-21.3%-23.8%
Q3 2023-11.2%-8.6%-7.5%
Q2 2023-6.5%-10.7%-18.7%
Q1 2023-3.7%-4.2%-13.1%
Q4 2022+0.3%+1.0%-11.8%
Q3 2022-18.8%-9.4%+7.7%
Q2 2022-3.4%-3.8%-10.3%
Q1 2022-2.8%+0.4%+5.2%
Q4 2021+10.8%+7.9%-4.3%
Q3 2021+6.1%+8.9%+10.5%
Q2 2021+0.9%-0.6%-7.0%
Q1 2021+11.7%+13.5%+17.0%
Q4 2020-13.0%-20.8%-14.9%
Q3 2020+3.9%-10.3%+0.9%
Q2 2020+2.3%+3.3%+3.1%
Q1 2020+28.3%+24.9%+44.6%
Q4 2019-13.4%-12.0%-43.6%
Q3 2019-15.3%-11.5%-19.2%
Q2 2019+5.8%+6.6%+11.9%
Q1 2019+26.9%+15.5%-4.9%
Q4 2018-7.4%+1.4%-9.7%
Q3 2018-13.4%-10.5%-12.1%
Q2 2018+15.7%+12.8%+8.9%
Q1 2018-1.1%+1.8%+11.8%
Q4 2017-1.6%+1.7%+5.8%
Q3 2017-4.3%-5.4%+4.3%
Q2 2017-2.9%-2.3%-2.1%
Q1 2017-2.5%+1.5%+1.7%
Q4 2016-12.3%-12.6%-4.6%
Q3 2016-8.7%-8.2%-14.0%
Q2 2016+12.2%+10.8%+11.1%
Q1 2016+3.2%
Q4 2015-11.3%
Q3 2015+4.5%
Q2 2015+16.2%
Q1 2015-5.0%
Q4 2014+18.4%
Q3 2014-19.6%
Q2 2014-17.4%
Q1 2014-10.9%
Q4 2013-5.8%
Q3 2013+8.6%
Q2 2013+5.3%
Q1 2013+5.0%
Q4 2012-0.7%
Q3 2012+16.7%
Q2 2012+15.9%
Q1 2012-12.8%
Q4 2011-0.1%
Q3 2011-3.9%
Q2 2011-4.0%
Q1 2010+1.6%
Q1 2011+1.6%
Q4 2008-2.0%
Q4 2010-2.0%
Q3 2010-2.1%
Q3 2009-2.1%
Q4 2009-6.1%
Q2 2010-6.1%
Q2 2009-6.1%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro